185 related articles for article (PubMed ID: 229053)
1. Induction of tumor resistance in mice by L1210 leukemia cells persistently infected with HVJ (Sendai virus).
Takeyama H; Kawashima K; Yamada K; Ito Y
Gan; 1979 Aug; 70(4):493-501. PubMed ID: 229053
[TBL] [Abstract][Full Text] [Related]
2. A significant role of proximity of HVJ-antigen in the generation of tumor immunity.
Kawashima K; Watanabe E; Kato Y; Suzuki H; Minami S; Isobe K; Ogura M; Nagura E; Yamada K
Gan; 1981 Dec; 72(6):955-8. PubMed ID: 6281118
[TBL] [Abstract][Full Text] [Related]
3. Common leukemia-associated antigen of DBA/2 mouse leukemia detected by tumor rejection and complement-dependent cytotoxicity assays.
Kawashima K; Takeyama H; Takahashi T; Kato Y; Watanabe E; Suzuki H; Minam S; Isobe K; Yamada K; Ito Y
Gan; 1979 Dec; 70(6):769-76. PubMed ID: 94022
[TBL] [Abstract][Full Text] [Related]
4. Curing of virus persistent infection in HVJ (sendai virus) carrier hamster tumor cells by transplantation.
Ogura H; Sato H; Hatano M
Gan; 1981 Aug; 72(4):498-503. PubMed ID: 6273248
[TBL] [Abstract][Full Text] [Related]
5. Direct activation of Sendai virus (HVJ)-specific cell-mediated immunity of mice for second set rejection of the virus-infected syngeneic tumor by noninfectious virus-sensitized spleen cells.
Kamihira O; Nakashima I; Hasegawa T; Ando K; Isobe K; Nagase F; Hasegawa Y; Yoshida T; Kawashima K; Yoshida T
Immunol Lett; 1985; 11(2):75-81. PubMed ID: 3002972
[TBL] [Abstract][Full Text] [Related]
6. In vitro curing of persistent infection of HVJ (sendai virus) carrier tumor cells by spleen cells.
Ogura H; Sato H; Hatano M
Gan; 1981 Aug; 72(4):504-11. PubMed ID: 6171472
[TBL] [Abstract][Full Text] [Related]
7. Induction of resistance to L1210 leukemia in BALB/c X DBA/2Cr F1 mice, with L1210 cells treated with glutaraldehyde and concanavalin A.
Kataoka T; Oh-hashi F; Tsukagoshi S; Sakurai Y
Cancer Res; 1977 Apr; 37(4):964-8. PubMed ID: 403001
[TBL] [Abstract][Full Text] [Related]
8. Relationship between establishment of persistent infection of haemagglutinating virus of Japan and the properties of the virus.
Nishiyama Y; Ito Y; Shimokata K; Kimura Y; Nagata I
J Gen Virol; 1976 Jul; 32(1):73-83. PubMed ID: 182915
[TBL] [Abstract][Full Text] [Related]
9. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
Rapp L; Fuji H
Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of a unique tumor-associated surface antigen on L1210 leukemia cells recognized by semisyngeneic antisera.
Yokochi T; Kawashima K; Nakashima I; Nagase F; Isobe K; Nagura E; Yamada K; Miyadai T; Kimura Y
Cancer Res; 1987 Feb; 47(4):1006-9. PubMed ID: 3542198
[TBL] [Abstract][Full Text] [Related]
11. Identification of the virions in the in vitro L1210(V) leukemia cell lines by morphological, virological, and immunological techniques.
Chen PL; Hutchison DJ; Sarkar NH; Kramarsky B; Moore DH
Cancer Res; 1975 Mar; 35(3):718-28. PubMed ID: 163689
[TBL] [Abstract][Full Text] [Related]
12. Induction of immune resistance against L1210 lymphatic leukemia in mice after chemoradiotherapy of the leukemia and reconstitution with bone marrow purged from the leukemia with mafosfamide.
Skórski T; Kawalec M
Exp Hematol; 1988 Oct; 16(9):782-4. PubMed ID: 3049130
[TBL] [Abstract][Full Text] [Related]
13. Relationship between tumor formation and cell-mediated immunity in hamsters with transplanted HVJ (Sendai virus)-carrying tumor cells.
Ogura H; Sato H; Tanaka J; Hatano M; Fukuda S; Morita O
Gan; 1980 Jun; 71(3):325-32. PubMed ID: 6252084
[TBL] [Abstract][Full Text] [Related]
14. Involvement of cytotoxic T-lymphocytes in the antitumor activity of spergualin against L1210 cells.
Umezawa H; Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T
Cancer Res; 1987 Jun; 47(12):3062-5. PubMed ID: 3495325
[TBL] [Abstract][Full Text] [Related]
15. Induction of transplantation resistance to murine L1210 leukemia cells in BCG-primed mice by immunization with tuberculin protein-coupled L1210 cells.
Ohno R; Kodera Y; Ogura M; Yamada H
Gan; 1984 Feb; 75(2):187-92. PubMed ID: 6428959
[TBL] [Abstract][Full Text] [Related]
16. Vesicular stomatitis virus-infected L1210 murine leukemia cells: increased immunogenicity and altered surface antigens.
Wise KS
J Natl Cancer Inst; 1977 Jan; 58(1):83-90. PubMed ID: 189042
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines.
Fuji H
Transplant Proc; 1980 Sep; 12(3):388-90. PubMed ID: 6784299
[TBL] [Abstract][Full Text] [Related]
18. Immunity to virus-free syngeneic tumor cell transplantation in the BALB/c mouse after immunization with homologous tumor cells infected with type C virus.
Al-Ghazzouli IK; Donahoe RM; Huang KY; Sass B; Peters RL; Kelloff GJ
J Immunol; 1976 Dec; 117(6):2239-48. PubMed ID: 186539
[TBL] [Abstract][Full Text] [Related]
19. Induction of high-grade tumor-specific immunity in a host using a cytotoxic T-lymphocyte clone specific for a stable tumor antigen on murine leukemia L1210.
Rahman SM; Kawashima K; Nakashima I; Nagase F
Cancer Res; 1988 Nov; 48(22):6450-4. PubMed ID: 3263189
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of the antibody forming cell response to neuraminidase-treated cells by myxoviruses.
Russell PH
Immunology; 1981 Dec; 44(4):781-7. PubMed ID: 6274794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
